Atlas Wealth Partners LLC Sells 100 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Atlas Wealth Partners LLC lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.8% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,000 shares of the medical equipment provider’s stock after selling 100 shares during the period. Intuitive Surgical comprises approximately 1.3% of Atlas Wealth Partners LLC’s holdings, making the stock its 13th biggest position. Atlas Wealth Partners LLC’s holdings in Intuitive Surgical were worth $1,044,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in ISRG. M.E. Allison & CO. Inc. purchased a new stake in Intuitive Surgical in the fourth quarter worth about $449,000. Seilern Investment Management Ltd purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $82,517,000. Sycomore Asset Management raised its stake in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after acquiring an additional 4,079 shares during the period. Exome Asset Management LLC lifted its holdings in Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. boosted its position in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.7 %

Shares of NASDAQ:ISRG opened at $591.65 on Wednesday. The firm has a fifty day simple moving average of $555.91 and a two-hundred day simple moving average of $515.92. The stock has a market capitalization of $210.73 billion, a P/E ratio of 92.30, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Citigroup raised their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Evercore ISI upped their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Raymond James lifted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Finally, Jefferies Financial Group upped their price target on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the transaction, the executive vice president now directly owns 353 shares of the company’s stock, valued at $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 6,348 shares of company stock valued at $3,587,582. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.